Adaptimmune Therapeutics shares owned by Partner Fund Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Partner Fund Management
from 13F filings
Historical chart of Partner Fund Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Partner Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $10M | 11M | 0.97 |
| 2024-03-31 | $17M | 10M | 1.58 |
| 2023-12-31 | $8.3M | 10M | 0.79 |
| 2023-09-30 | $8.1M | 10M | 0.78 |
| 2023-06-30 | $7.7M | 8.4M | 0.93 |
| 2023-03-31 | $6.5M | 6.0M | 1.09 |
| 2022-12-31 | $7.1M | 4.8M | 1.46 |
| 2022-09-30 | $10M | 9.3M | 1.08 |
| 2022-06-30 | $16M | 9.1M | 1.70 |
| 2022-03-31 | $4.9M | 2.4M | 2.06 |
| 2021-12-31 | $12M | 3.2M | 3.75 |
| 2021-09-30 | $23M | 4.4M | 5.17 |
| 2021-06-30 | $16M | 3.6M | 4.26 |
| 2021-03-31 | $13M | 2.5M | 5.31 |
| 2020-12-31 | $15M | 2.7M | 5.39 |
| 2020-09-30 | $6.8M | 849k | 7.98 |
| 2015-09-30 | $12M | 1.0M | 11.97 |
| 2015-06-30 | $18M | 966k | 18.33 |